SB 1404: Cancer Clinical Trials
GENERAL BILL by Simmons
Cancer Clinical Trials; Requiring cancer clinical trial programs to inform prospective patient subjects of the specified reimbursements for ancillary costs and travel expenses which may be available to them and their caregivers if they participate in a cancer clinical trial; specifying that reimbursement offers may not be coercive or exert an undue influence and are not considered inducements for participation; requiring certain entities that offer reimbursement programs to secure the informed consent of patient subjects, etc.
Effective Date: 7/1/2018
Last Action: 3/10/2018 Senate - Died in Health Policy
Bill Text: Web Page | PDF
Last Action: 3/10/2018 Senate - Died in Health Policy
Bill Text: Web Page | PDF
Senate Committee References:
- Health Policy (HP)
- Appropriations Subcommittee on Health and Human Services (AHS)
- Appropriations (AP)
- Rules (RC)
-
Bill History
Date Chamber Action 12/28/2017 Senate • Filed
1/12/2018 Senate • Referred to Health Policy; Appropriations Subcommittee on Health and Human Services; Appropriations; Rules -SJ 165
1/17/2018 Senate • Introduced -SJ 165
3/10/2018 Senate • Indefinitely postponed and withdrawn from consideration
• Died in Health Policy
-
SB 1404, Original Filed Version (Current Bill Version) Posted 12/28/2017 at 4:18 PM
Bill Text: Web Page | PDF Analyses: None Citations - Statutes (1)
Citation Catchline Location in Bill Location In Bill Help 385.2021 Page 1 (pdf)